Tarceva is used to treat patients with advanced non-small cell lung cancer (NSCLC):

that is only in the lung (local), or spread through the body (metastatic), and

who have failed at least one other chemotherapy treatment (medicine used to kill cancer cells) .

Special Warning(s) with Tarceva:

  • Some patients taking Tarceva have developed interstitial lung disease (ILD). ILD is a serious and life-threatening lung disease. The symptoms of ILD are the sudden onset or worsening of trouble breathing (shortness of breath) and dry cough.
  • Women who are pregnant or breast feeding should not take Tarceva. Women of child-bearing age should avoid becoming pregnant while taking Tarceva. Effective birth control should be used during Tarceva therapy and for two weeks after stopping Tarceva.

General Precautions with Tarceva:

Patients on Tarceva therapy and taking warfarin (Coumadin) or other medicines called "anti-coagulants" should have regular blood tests and watch for bleeding problems.

GoldBamboo

Image:Erlotinib.png Erlotinib Systematic (IUPAC) name N-(3-ethynyl ...
Wikipedia - [full article]

From the WEST  scientific·clinical

From the EAST  traditional·alternative





Tarceva Other

1 of 1
Tarceva Consumer Information
... Tarceva is used to treat patients with advanced non-small cell lung cancer (NSCLC): that is only in the lung (local), or spread through the body (metastatic), and who have failed at least one othe...
Source: U.S. Food and Drug Administration

   

Tarceva Articles

  • Tarceva Consumer Information
    ... Tarceva is used to treat patients with advanced non-small cell lung cancer (NSCLC): that is only in the lung (local), or spread through the body (metastatic), and who have failed at least one othe...

Resources